STOCK TITAN

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Adaptive Biotechnologies (ADPT) will host a business update conference call and webcast on April 2, 2024, aiming to translate genetics of the adaptive immune system into clinical products for disease diagnosis and treatment.
Positive
  • None.
Negative
  • None.

SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will host a business update conference call and webcast after market close on Tuesday, April 2, 2024 beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event.

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Director, Corporate Communications
206-279-2423
media@adaptivebiotech.com


FAQ

When will Adaptive Biotechnologies host a business update conference call and webcast?

Adaptive Biotechnologies will host a business update conference call and webcast on April 2, 2024.

What is the ticker symbol for Adaptive Biotechnologies ?

The ticker symbol for Adaptive Biotechnologies is ADPT.

What is the focus of Adaptive Biotechnologies ?

Adaptive Biotechnologies aims to translate the genetics of the adaptive immune system into clinical products for disease diagnosis and treatment.

Where can I access the live audio of the webcast?

The live audio of the webcast will be available on the 'Investors' section of the company website at www.adaptivebiotech.com.

Will the webcast be available for replay?

Yes, the webcast will be archived and available for replay within 24 hours after the event.

Adaptive Biotechnologies Corporation

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Stock Data

655.79M
147.37M
2.02%
100.66%
8.85%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
SEATTLE